These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3332516)

  • 1. Immunotherapy of infectious diseases: past, present and future.
    Pennington JE
    Trans Am Clin Climatol Assoc; 1988; 99():126-35. PubMed ID: 3332516
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do immunoglobulins have a value and a future in the treatment of severe bacterial infections?].
    Baumgartner JD
    Presse Med; 1990 Feb; 19(5):196-8. PubMed ID: 2137913
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy with immunoglobulins].
    Schumacher K
    Dtsch Med Wochenschr; 1986 Apr; 111(14):550-6. PubMed ID: 3514195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human immunoglobulin for intravenous administration in the treatment of infectious and inflammatory diseases in children].
    Vorob'eva VA; Shilenok IG; Azova EA; Darovskaia TE; Repina AN; Kiseleva IA; Anastasiev VV; Budtsina MV
    Pediatriia; 1990; (8):74-8. PubMed ID: 2259580
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of cancer with L-phenylalanine mustard as a hapten.
    Arai K; Wallace HW; Blakemore WS
    Cancer Res; 1973 Aug; 33(8):1914-20. PubMed ID: 4720800
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications for passive immunotherapy in infectious diseases].
    Baumgartner JD
    Schweiz Med Wochenschr; 1987 Jan; 117(3):84-90. PubMed ID: 3823822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the socio-economic effect of using immune anti- meningococcal plasma in pediatric practice].
    Smirnova AI; Kochetygina AA; Nikolaeva LK; Zinchenko AP; Sorokina MN; Romanchenko TG
    Pediatriia; 1990; (3):36-9. PubMed ID: 2143575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of intravenous gamma-globulin use in neonates.
    Gonzalez LA; Hill HR
    Pediatr Infect Dis J; 1989 May; 8(5):315-22. PubMed ID: 2471136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complications during treatment with antireticular cytotoxic serum and their prevention].
    Miagkaia IP
    Klin Med (Mosk); 1975 Apr; 53(4):107-11. PubMed ID: 50474
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of a symposium: Intravenous immunoglobulin therapy of infections in newborns and infants. September 1985, Interlaken, Switzerland.
    Pediatr Infect Dis; 1986; 5(3 Suppl):S163-219. PubMed ID: 3714522
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of intravenous immunoglobulin in the treatment and prevention of neonatal bacterial infection.
    Hill HR
    Semin Perinatol; 1991 Jun; 15(3 Suppl 2):41-6. PubMed ID: 1887261
    [No Abstract]   [Full Text] [Related]  

  • 12. Rabies hyperimmune serum.
    J Okla State Med Assoc; 1973 May; 66(5):211. PubMed ID: 4736590
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytolytic effects of alloantiserum in patients with lymphoproliferative disorders.
    Herberman RB; Oren ME; Rogentine GN; Fahey JL
    Cancer; 1971 Aug; 28(2):365-71. PubMed ID: 5566358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of antegrade endolymphatic administration of antistaphylococcal and antipseudomonal plasma in the treatment of infectious complications in severe multiple trauma].
    Eriukhin IA; Rybkin AK; Vorob'ev VV; Kaleko SP
    Khirurgiia (Mosk); 1995; (3):49-51. PubMed ID: 7630089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of passive immunization on experimental syphilis in the rabbit.
    Turner TB; Hardy PH; Newman B; Nell EE
    Johns Hopkins Med J; 1973 Nov; 133(5):241-51. PubMed ID: 4586309
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of intravenous immunoglobulin in prevention and treatment of neonatal infection.
    Irani SF; Wagle SU; Deshpande PG
    Indian Pediatr; 1991 Apr; 28(4):443-9. PubMed ID: 1721607
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals.
    Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; McPhee DA; McLachlan AJ; Gelder FB; Lewin SR; Liauw W; Williams KM
    HIV Clin Trials; 2004; 5(2):91-8. PubMed ID: 15116285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future horizons.
    Ahmed AR
    Int Immunopharmacol; 2006 Apr; 6(4):607-9. PubMed ID: 16504923
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential for intravenous gamma-globulin use in neonatal gram-negative infection: an overview.
    Bortolussi R
    Pediatr Infect Dis; 1986; 5(3 Suppl):S198-200. PubMed ID: 3520507
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous immunoglobulin for prophylaxis or treatment of bacterial infection in neonates.
    Christensen RD
    J Perinatol; 1987; 7(1):58-61. PubMed ID: 3333793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.